Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?

研究成果: Letter › 同行評審

原文	English
頁（從 - 到）	170-171
頁數	2
期刊	Journal of Microbiology, Immunology and Infection
卷	55
發行號	1
DOIs	https://doi.org/10.1016/j.jmii.2021.07.016
出版狀態	Published - 2022 2月

All Science Journal Classification (ASJC) codes

@article{956c484af9ff4faf8c52e855116aed2d,

title = "Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?",

author = "Lo, {Ching Lung} and Syue, {Ling Shan} and Ko, {Wen Chien}",

year = "2022",

month = feb,

doi = "10.1016/j.jmii.2021.07.016",

language = "English",

volume = "55",

pages = "170--171",

journal = "Journal of Microbiology, Immunology and Infection",

issn = "1684-1182",

publisher = "Elsevier Taiwan LLC",

number = "1",

}

TY - JOUR

T1 - Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia

T2 - Can an early dose herald a better outcome?

AU - Lo, Ching Lung

AU - Syue, Ling Shan

AU - Ko, Wen Chien

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85124624507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124624507&partnerID=8YFLogxK

U2 - 10.1016/j.jmii.2021.07.016

DO - 10.1016/j.jmii.2021.07.016

M3 - Letter

C2 - 34654666

AN - SCOPUS:85124624507

SN - 1684-1182

VL - 55

SP - 170

EP - 171

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

IS - 1

ER -